Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
Clinical trial NCT04529850 · COMPLETED
Trial details
- NCT number
- NCT04529850
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-03-10
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.